Spark touts animal data for a solution to AAV gene therapy's antibody problem

Spark touts animal data for a solution to AAV gene therapy's antibody problem

Source: 
Endpoints
snippet: 

Among all the limitations of using an adeno-associated virus as a vector to deliver a gene — still the most established modality in gene therapy given years of trial and error and finally success — the presence of neutralizing antibodies, whether pre-existing or induced, looms large.